Exclusive

Publication

Byline

Location

US Patent Issued to BioNTech on June 30 for "RNA formulations suitable for therapy" (German Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,621, issued on June 30, was assigned to BioNTech SE (Mainz, Germany). "RNA formulations suitable for therapy" was invented by Heinrich Haas... Read More


US Patent Issued to TECHNION RESEARCH & DEVELOPMENT FOUNDATION on June 30 for "Composition and method for a prebiotic delivery system targeted to probiotic bacteria" (Israeli Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,622, issued on June 30, was assigned to TECHNION RESEARCH & DEVELOPMENT FOUNDATION Ltd. (Haifa, Israel). "Composition and method for a preb... Read More


US Patent Issued to University of Mississippi Medical Center on June 30 for "Kidney-targeted drug delivery systems" (Mississippi Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,623, issued on June 30, was assigned to University of Mississippi Medical Center (Jackson, Miss.). "Kidney-targeted drug delivery systems" ... Read More


US Patent Issued to HANMI PHARM. on June 30 for "GIP derivative, long-acting conjugate thereof, and pharmaceutical composition comprising same" (South Korean Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,624, issued on June 30, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea). "GIP derivative, long-acting conjugate thereof, a... Read More


US Patent Issued to INATHERYS on June 30 for "Antibody-drug conjucates and their uses for the treatment of cancer" (French Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,625, issued on June 30, was assigned to INATHERYS (Evry Cedex, France). "Antibody-drug conjucates and their uses for the treatment of cance... Read More


US Patent Issued to PRESIDENT AND FELLOWS OF HARVARD COLLEGE on June 30 for "Compositions and methods relating to erythrocytes with adhered particles" (Massachusetts Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,626, issued on June 30, was assigned to PRESIDENT AND FELLOWS OF HARVARD COLLEGE. "Compositions and methods relating to erythrocytes with a... Read More


US Patent Issued to Acuitas Therapeutics on June 30 for "Lipids and lipid nanoparticle formulations for delivery of nucleic acids" (Canadian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,627, issued on June 30, was assigned to Acuitas Therapeutics Inc. (Vancouver, Canada). "Lipids and lipid nanoparticle formulations for deli... Read More


US Patent Issued to Children's Medical Center on June 30 for "Compositions and methods for gene replacement" (Massachusetts Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,628, issued on June 30, was assigned to Children's Medical Center Corp. (Boston). "Compositions and methods for gene replacement" was inven... Read More


US Patent Issued to University of Florida Research Foundation on June 30 for "Increased packaging efficiency of vector for cardiac gene therapy" (Florida Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,629, issued on June 30, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.). "Increased packaging efficiency... Read More


US Patent Issued to FIVE ELEVEN PHARMA, BIOMOLECULAR PROBES BIOTECHNOLOGY (BEIJING) on June 30 for "Radioactively labeled ligand for fibroblast activation protein-alpha imaging agent and preparation method therefor" (American, Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,630, issued on June 30, was assigned to FIVE ELEVEN PHARMA INC (Philadelphia) and BIOMOLECULAR PROBES BIOTECHNOLOGY (BEIJING) Co. LTD (Beiji... Read More